Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARTERIAL VASCULAR ENGINEERING -- Ignore unavailable to you. Want to Upgrade?

To: Zeus549 who wrote (291)	11/3/1997 5:56:00 PM
From: D.E. Shetland	Read Replies (1) \| Respond to of 339

I believe most of the US lawsuits are on JNJ's patent concerning stents on baloons. Of course, that's how all stents are positioned, but I believe some feel that JNJ's patent does not cover certain methods. I also think that it all expires soon anyway. Sorry for not being more definative. I think the general consensus has been that JNJ is desperately trying to delay competition coming into the US market.

To: Zeus549 who wrote (291)	11/3/1997 10:25:00 PM
From: bullw	Respond to of 339

Lee, The Forbes article on AVE is in the Streetwalker section of the October 20 issue. Can find the article at forbes.com and then go to search. Good luck and thanks for your reference concerning Stockwatch.

To: Zeus549 who wrote (291)	11/4/1997 7:01:00 PM
From: Jeff Gurian	Read Replies (1) \| Respond to of 339

Im back in. Market appears stable enough, for me at least. Price trend was up, and like I said before, Im not counting on another market shock or AVE pullback. I bought some for long term and some to play around with. I figure to sell my "play" shares around 60 and buy back in on any dips. I dont like doing this very much, but I think I/we know enough about AVE trends to do this with a little more confidence than most other stocks. Besides, its only money.